Results 61 to 70 of about 268,545 (217)

Advanced Primary Cervical Carcinosarcoma With Ovarian and Peritoneal Metastases in a Premenopausal Woman: A Rare Case Report From Northern Tanzania

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Cervical carcinosarcoma (CCS), also known as malignant mixed Müllerian tumor (MMMT) of the cervix, is an exceptionally rare and aggressive biphasic neoplasm composed of both epithelial and mesenchymal malignant components. Due to its rarity, optimal management strategies are not well established, particularly in low‐resource settings.
John Lugata   +11 more
wiley   +1 more source

Sonar findings of the uterus in patients on medroxyprogesterone acetate (Depo Provera) 150 mg injection

open access: yesSouth African Family Practice, 2009
Background: Depo Provera (medroxyprogesterone acetate) 150 mg intramuscular injection every 12 weeks is one of the most common, effective, affordable and popular methods of contraception.
Louis A. de Wilde   +2 more
doaj   +1 more source

Association of novel intra‐cesarean post‐placental intrauterine device insertion techniques, and early ultrasound, with expulsion rates and strings visibility: A prospective exploratory study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 226-232, October 2026.
Abstract Objective To assess an innovative technique of intra‐cesarean post‐placental insertion of the Copper T380A IUD (CPPIUD), and explore the role of predischarge ultrasound with replacement of low‐lying IUDs. Methods We conducted a prospective observational study at Princess Marina Hospital, Gaborone, Botswana, from May 31, 2023, to April 3, 2024.
Kyungu M. Kime   +2 more
wiley   +1 more source

A case report and literature review: A 19‐year‐old with endometrial carcinoma treated with medroxyprogesterone acetate. Importance of the medical interview and endometrial examination

open access: yesClinical Case Reports
Key Clinical Message A 19‐year‐old woman had stage IA endometrial carcinoma treated with medroxyprogesterone acetate and experienced a recurrence. This patient's experience illustrates the importance of a thorough history and endometrial assessment in ...
Shinichiro Katsuma   +4 more
doaj   +1 more source

Preoperative and postoperative pathology concordance in endometrial intraepithelial neoplasia: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 336-344, October 2026.
Abstract Objective To assess the concordance between pre‐ and postoperative pathology in patients with endometrial intraepithelial neoplasia (EIN) undergoing hysterectomy, and identify predictors of malignancy, including sampling method, progestin therapy, and surgical timing.
Jenny Dimakos   +6 more
wiley   +1 more source

Effects of medroxyprogesterone acetate on human cytochrome P450 enzymes

open access: yes, 2005
Medroxyprogesterone acetate (MPA), frequently used in contraception and chemotherapy, was reported involving in drug-drug interaction (DDI). However, the mechanism is still unclear.
张江伟, 李巍, 刘勇, 杨凌
core  

Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer [PDF]

open access: yes, 1989
The effect of high-dose medroxyprogesterone acetate was studied in 7 patients with advanced prostatic cancer. Results in 7 patients were no change (NC) in 5 (71%) and progressive disease (PD) in 2 patients (29%). However, pain relief was obtained in 6 of
梅田, 慶一   +3 more
core  

Perbedaan Profil Lipid pada Akseptor Depo Medroksi Progesteron Asetat dengan Implant Levonorgestrel di Wilayah Kerja Puskesmas Air Tawar Padang Tahun 2014

open access: yesJurnal Kesehatan Andalas, 2015
AbstrakDepo Medroksiprogesteron Asetat dan Implant Levonorgestrel merupakan kontrasepsi hormonal progestin sintetik yang memiliki efek samping yaitu peningkatan berat badan dan mempengaruhi metabolisme lipid. Tujuan penelitian ini adalah untuk mengetahui
Rafika Oktova, Desmiwarti ., Arni Amir
doaj  

Efficacy and related factors of levonorgestrel‐releasing intrauterine system combined with metformin in fertility‐preserving treatment for atypical endometrial hyperplasia and early endometrial cancer: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 396-407, October 2026.
Abstract Objective To compare the efficacy of the levonorgestrel‐releasing intrauterine system combined with metformin versus oral progestin combined with metformin in fertility‐preserving treatment for patients with atypical endometrial hyperplasia and early endometrial cancer, and to analyze related factors affecting efficacy.
Pengpeng Gu   +5 more
wiley   +1 more source

Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17β-estradiol and norethindrone acetate

open access: yes, 2001
OBJECTIVE: We studied bleeding patterns in postmenopausal women who were using 2 types of continuous combination regimens. STUDY DESIGN: A prospective, double-blind, randomized study of 208 postmenopausal women treated with conjugated estrogen, 0.625 mg,
Torbjörn Bäckström   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy